154 related articles for article (PubMed ID: 26474971)
21. TP53 mutation hits energy metabolism and increases glycolysis in breast cancer.
Harami-Papp H; Pongor LS; Munkácsy G; Horváth G; Nagy ÁM; Ambrus A; Hauser P; Szabó A; Tretter L; Győrffy B
Oncotarget; 2016 Oct; 7(41):67183-67195. PubMed ID: 27582538
[TBL] [Abstract][Full Text] [Related]
22. An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome.
Zhou S; Kassauei K; Cutler DJ; Kennedy GC; Sidransky D; Maitra A; Califano J
J Mol Diagn; 2006 Sep; 8(4):476-82. PubMed ID: 16931588
[TBL] [Abstract][Full Text] [Related]
23. DriverDBv2: a database for human cancer driver gene research.
Chung IF; Chen CY; Su SC; Li CY; Wu KJ; Wang HW; Cheng WC
Nucleic Acids Res; 2016 Jan; 44(D1):D975-9. PubMed ID: 26635391
[TBL] [Abstract][Full Text] [Related]
24. The mutational landscape of the SCAN-B real-world primary breast cancer transcriptome.
Brueffer C; Gladchuk S; Winter C; Vallon-Christersson J; Hegardt C; Häkkinen J; George AM; Chen Y; Ehinger A; Larsson C; Loman N; Malmberg M; Rydén L; Borg Å; Saal LH
EMBO Mol Med; 2020 Oct; 12(10):e12118. PubMed ID: 32926574
[TBL] [Abstract][Full Text] [Related]
25. Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results.
Rahman M; Jackson LK; Johnson WE; Li DY; Bild AH; Piccolo SR
Bioinformatics; 2015 Nov; 31(22):3666-72. PubMed ID: 26209429
[TBL] [Abstract][Full Text] [Related]
26. Statistically identifying tumor suppressors and oncogenes from pan-cancer genome-sequencing data.
Kumar RD; Searleman AC; Swamidass SJ; Griffith OL; Bose R
Bioinformatics; 2015 Nov; 31(22):3561-8. PubMed ID: 26209800
[TBL] [Abstract][Full Text] [Related]
27. Unifying cancer and normal RNA sequencing data from different sources.
Wang Q; Armenia J; Zhang C; Penson AV; Reznik E; Zhang L; Minet T; Ochoa A; Gross BE; Iacobuzio-Donahue CA; Betel D; Taylor BS; Gao J; Schultz N
Sci Data; 2018 Apr; 5():180061. PubMed ID: 29664468
[TBL] [Abstract][Full Text] [Related]
28. [Internet-based opportunities in breast cancer diagnostics and research].
Nagy Á; Gyõrffy B
Magy Onkol; 2016 Nov; 60(4):273-280. PubMed ID: 27898745
[TBL] [Abstract][Full Text] [Related]
29. MassARRAY determination of somatic oncogenic mutations in solid tumors: Moving forward to personalized medicine.
Fleitas T; Ibarrola-Villava M; Ribas G; Cervantes A
Cancer Treat Rev; 2016 Sep; 49():57-64. PubMed ID: 27501018
[TBL] [Abstract][Full Text] [Related]
30. Next-generation sequencing.
Reis-Filho JS
Breast Cancer Res; 2009; 11 Suppl 3(Suppl 3):S12. PubMed ID: 20030863
[TBL] [Abstract][Full Text] [Related]
31. CAMUR: Knowledge extraction from RNA-seq cancer data through equivalent classification rules.
Cestarelli V; Fiscon G; Felici G; Bertolazzi P; Weitschek E
Bioinformatics; 2016 Mar; 32(5):697-704. PubMed ID: 26519501
[TBL] [Abstract][Full Text] [Related]
32. The transcript-centric mutations in human genomes.
Cui P; Lin Q; Ding F; Hu S; Yu J
Genomics Proteomics Bioinformatics; 2012 Feb; 10(1):11-22. PubMed ID: 22449397
[TBL] [Abstract][Full Text] [Related]
33. DrGA: cancer driver gene analysis in a simpler manner.
Nguyen QH; Nguyen T; Le DH
BMC Bioinformatics; 2022 Mar; 23(1):86. PubMed ID: 35247965
[TBL] [Abstract][Full Text] [Related]
34. A quantum leap in our knowledge of breast cancer mutations.
Caldas C; Edwards PA
Breast Cancer Res; 2006; 8(6):304. PubMed ID: 17184559
[No Abstract] [Full Text] [Related]
35. TARGET-seq Takes Aim at Cancer Evolution through Multi-omics Single-Cell Genotyping and Transcriptomics.
Chaligne R; Nam AS; Landau DA
Mol Cell; 2019 Mar; 73(6):1092-1094. PubMed ID: 30901562
[TBL] [Abstract][Full Text] [Related]
36. Decoding the evolution of a breast cancer genome.
Bedard PL; Sotiriou C
EMBO Mol Med; 2010 Jan; 2(1):3-5. PubMed ID: 20043280
[TBL] [Abstract][Full Text] [Related]
37. A CHIP mutation to battle cancer: potential or hazard for cardiovascular disease?
Leuschner F
Cardiovasc Res; 2018 Nov; 114(13):e96-e98. PubMed ID: 30351373
[No Abstract] [Full Text] [Related]
38. Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing.
Roy-Chowdhuri S; de Melo Gagliato D; Routbort MJ; Patel KP; Singh RR; Broaddus R; Lazar AJ; Sahin A; Alvarez RH; Moulder S; Wheler JJ; Janku F; Gonzalez-Angulo AM; Chavez-MacGregor M; Valero V; Ueno NT; Mills G; Mendelsohn J; Yao H; Aldape K; Luthra R; Meric-Bernstam F
Am J Clin Pathol; 2015 Nov; 144(5):713-21. PubMed ID: 26486734
[TBL] [Abstract][Full Text] [Related]
39. Revealing the Complexity of Breast Cancer by Next Generation Sequencing.
Verigos J; Magklara A
Cancers (Basel); 2015 Nov; 7(4):2183-200. PubMed ID: 26561834
[TBL] [Abstract][Full Text] [Related]
40. Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families.
Li J; Meeks H; Feng BJ; Healey S; Thorne H; Makunin I; Ellis J; ; Campbell I; Southey M; Mitchell G; Clouston D; Kirk J; Goldgar D; Chenevix-Trench G
J Med Genet; 2016 Jan; 53(1):34-42. PubMed ID: 26534844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
